Dexcom (DXCM)
NASDAQHealth CareMedical DevicesSnapshot 2026-07-07
$73.57+1.64%
Close 2026-07-07 · 1-day change
Reading DXCM? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track DXCM free→NASDAQHealth CareMedical DevicesSnapshot 2026-07-07
Reading DXCM? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track DXCM free→QuarterlyIQ Insights · DXCM
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 4,817.9 | 4,662.0 | 4,033.0 | 3,622.3 | 2,909.8 | 2,448.5 | 1,926.7 | 1,476.0 | 573.3 | 221.0 | 171.2 | 130.8 | 84.3 | 99.9 | 99.9 | 76.3 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 221.0 | 171.2 | 130.8 | 84.3 | 99.9 | 99.9 | 76.3 |
| Cost of Revenues | 1,854.7 | 1,860.1 | 1,594.8 | 1,333.4 | 1,026.7 | 768.0 | 646.6 | 544.5 | 194.9 | — | 194.9 | 123.6 | 53.3 | 53.3 | 53.3 | 40.4 |
| Gross Profit | 2,963.2 | 2,801.9 | 2,438.2 | 2,288.9 | 1,883.1 | 1,680.5 | 1,280.1 | 931.5 | 378.4 | 378.4 | 378.4 | 278.4 | 46.6 | 46.6 | 46.6 | 35.8 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 1,330.6 | 1,291.0 | 1,285.8 | 1,185.4 | 1,007.7 | 810.5 | 618.2 | 515.7 | 286.2 | 286.2 | 286.2 | 198.0 | 64.0 | 64.0 | 62.8 | 49.9 |
| R&D Expenses | 599.2 | 599.1 | 552.4 | 505.8 | 484.2 | 517.1 | 359.9 | 273.5 | 156.1 | 156.1 | 156.1 | 137.5 | 38.3 | 38.3 | 39.5 | 30.7 |
| Other Operating Expenses, Total | 0.9 | 4.1 | (4.8) | (3.9) | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Income | 1,033.4 | 911.8 | 600.0 | 597.7 | 391.2 | 265.8 | 299.5 | 142.3 | (63.9) | (63.9) | (63.9) | (57.1) | (55.7) | (55.7) | (55.7) | (44.8) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | 20.3 | 18.6 | 18.8 | 17.7 | 60.3 | 0.7 | 0.7 | 0.7 | 0.4 | 0.2 | 0.2 | 0.2 | 0.0 |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | 0.4 | 0.4 | — | — | — | — | 0.1 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | 0.3 | 0.3 | — | — | — | — | (0.1) |
| EBT, Incl. Unusual Items | 1,203.6 | 1,088.4 | 709.0 | 710.4 | 390.8 | 256.8 | 225.0 | 104.2 | (64.9) | (64.9) | (64.9) | (57.5) | (55.8) | (55.8) | (55.8) | — |
| Income Tax Expense | 273.2 | 252.1 | 132.8 | 168.9 | 49.6 | 39.9 | (251.8) | 3.1 | 0.7 | 0.7 | 0.7 | 0.1 | (1.3) | (1.3) | (1.3) | (0.0) |
| Net Income | ||||||||||||||||
| Net Income | 930.4 | 836.3 | 576.2 | 541.5 | 341.2 | 216.9 | 549.7 | 101.1 | (65.6) | (65.6) | (65.6) | (57.6) | (54.5) | (54.5) | (54.5) | (44.7) |
| Per Share | ||||||||||||||||
| Basic EPS | 2.42 | 2.14 | 1.46 | 1.40 | 0.88 | 0.56 | 1.46 | 1.11 | (2.03) | — | — | — | — | — | — | — |
| Diluted EPS | 2.36 | 2.09 | 1.42 | 1.30 | 0.82 | 0.53 | 1.33 | 1.10 | (2.03) | — | — | — | — | — | — | — |
| Revenue per Share | 12.24 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 385.1 | 390.2 | 393.6 | 386.0 | 389.4 | 386.9 | 377.5 | 91.1 | — | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 393.6 | 405.5 | 412.7 | 425.5 | 427.5 | 428.8 | 420.4 | 92.3 | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | 951.3 | 639.9 | 639.6 | 437.9 | 367.8 | 366.6 | 191.0 | (48.9) | (48.9) | (48.9) | (46.3) | (49.1) | (49.1) | (49.6) | (41.0) |
| EBIT | 1,033.4 | 911.8 | 600.0 | 597.7 | 391.2 | 265.8 | 299.5 | 142.3 | (63.9) | (63.9) | (63.9) | (57.1) | (55.7) | (55.7) | (55.7) | (44.8) |
| Effective Tax Rate | 22.7% | 23.2% | 18.7% | 23.8% | 12.7% | 15.5% | -111.9% | 3.0% | -1.1% | -1.1% | -1.1% | -0.2% | 2.3% | 2.3% | 2.3% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.